Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 10651 - 10675 of 11543 in total
Experimental
Matched Iupac: … N-[(morpholin-4-yl)methyl]pyrazine-2-carboxamide …
Experimental
Matched Iupac: … 6-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidin-4-one …
Experimental
Matched Iupac: … 6-benzyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidin-4-one …
Hopantenic acid (Pantogam) is a central nervous system depressant. Hopantenic acid has a unique spectrum of pharmacological effects (nootropic, anticonvulsant, mild activating) in the absence of addiction, hyperstimulation or withdrawal syndrome.
Experimental
Matched Iupac: … 4-[(2R)-2,4-dihydroxy-3,3-dimethylbutanamido]butanoic acid …
Investigational
Matched Iupac: … (2S)-4-carbamoyl-2-(2-phenylacetamido)butanoic acid …
Experimental
Matched Iupac: … (2S)-2-(carboxyamino)-4-(methylsulfanyl)butanoic acid …
Experimental
Matched Iupac: … (2S)-2-amino-N-hydroxy-4-methylpentanamide …
Experimental
Matched Iupac: … N2-[(4-methoxyphenyl)methyl]thiophene-2,5-disulfonamide …
Experimental
Matched Iupac: … (2R)-4-methyl-2-(methylamino)pentanoic acid …
Withdrawn from the Canadian market in July 1964 due to interactions with food products containing tyrosine.
Withdrawn
Matched Iupac: … N'-(propan-2-yl)pyridine-4-carbohydrazide …
OT-551 is a novel small molecule that is topically dosed in an eye drop and has the unique ability to penetrate cell membranes and reach both the front and the back of the eye. It is intended to treat Age-related macular Degeneration (AMD), and preclinical research results indicate additional uses...
Investigational
Matched Iupac: … 1-hydroxy-2,2,6,6-tetramethylpiperidin-4-yl cyclopropanecarboxylate …
Clomethiazole is a well-established γ-aminobutyric acid (GABAA)-mimetic drug. It is a sedative and hypnotic that is widely used in treating and preventing symptoms of acute alcohol withdrawal. It is a drug which is structurally related to thiamine (vitamin B1) but acts like a sedative, hypnotic, muscle relaxant and anticonvulsant. It...
Investigational
Matched Iupac: … 5-(2-chloroethyl)-4-methyl-1,3-thiazole …
Experimental
Matched Iupac: … 2-{[1,1'-biphenyl]-4-yl}acetic acid …
Diloxanide (as Diloxanide furoate) is an anti-protozoal drug used in the treatment of Entamoeba histolytica and some other protozoal infections. Although it is not currently approved for use in the United States, it was approved by a CDC study in the treatment of 4,371 cases of Entamoeba histolytica from 1977...
Experimental
Matched Iupac: … 2,2-dichloro-N-(4-hydroxyphenyl)-N-methylacetamide …
Benzylfentanyl (R-4129) is a fentanyl analog opioid that was on the list of Schedule I drugs in America in 1985 due to its structural similarity to fentanyl. In 2010 it was removed from the list after it was found to have minimal opioid activity. Benzylfentanyl has a Ki of 213nM...
Illicit
Matched Iupac: … N-(1-benzylpiperidin-4-yl)-N-phenylpropanamide …
Cythioate is a member of the organothiophosphate compounds that is used as an insecticide and anthelmintic. It is mainly used in veterinary as a treatment for fleas.
Vet approved
Matched Iupac: … O,O-dimethyl O-4-sulfamoylphenyl phosphorothioate …
Theanine, a precursor of ethylamine, is found in green tea. It is under investigation in clinical trial NCT00291070 (Effects of L-Theanine in Boys With ADHD).
Investigational
Matched Iupac: … (2S)-2-amino-4-(ethylcarbamoyl)butanoic acid …
Tetrasul has been used in trials studying the treatment of Erythematous (Type One) Rosacea.
Investigational
Matched Iupac: … 1,2,4-trichloro-5-[(4-chlorophenyl)sulfanyl]benzene …
Cloridarol is an experimental medication in the treatment of heart disease, which acts through vasodilation. It was studied for the treatment of coronary insufficiency in Italy in the 1970s .
Experimental
Matched Iupac: … (1-benzofuran-2-yl)(4-chlorophenyl)methanol …
Experimental
Matched Iupac: … 2-(dimethylamino)ethyl 2-(4-chlorophenoxy)acetate …
Experimental
Matched Iupac: … [2-(iodomethyl)-1,3-dioxolan-4-yl]methanol …
Experimental
Matched Iupac: … (2S)-2-(2-aminoacetamido)-4-carbamoylbutanoic acid …
Ladarixin is under investigation in clinical trial NCT04628481 (A Study of Oral Ladarixin in New-onset Type 1 Diabetes and a Low Residual Β-Cell Function).
Investigational
Matched Iupac: … 4-[(1R)-1-(methanesulfonylcarbamoyl)ethyl]phenyl trifluoromethanesulfonate …
Experimental
Matched Iupac: … 5-[(2S)-2-amino-2-carboxyethyl]-1-phosphono-1H-imidazol-3-ium …
Quisqualic acid is an agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium mobilization from intracellular stores. The compound is obtained from the seeds and fruit of Quisqualis chinensis.
Experimental
Matched Iupac: … (2S)-2-amino-3-(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)propanoic acid …
Displaying drugs 10651 - 10675 of 11543 in total